SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Trinity Biotech (TRIBY) -- Ignore unavailable to you. Want to Upgrade?


To: Keiko who wrote (7844)1/20/1998 2:58:00 AM
From: milton  Read Replies (1) | Respond to of 14328
 
Keiko
Just a comment on the misleading nature of triby's past earnings picture. The published earnings data shows 12/31/96 data such as quicken.excite.com which shows -.01 per share and a misleading statement of 1998 eps of .07. Another page shows similar misleading info such as www1.wsrn.com This points up why I wish triby either set up an effective home page or else put their PR people to work in getting out the current earnings picture. No mention is made of the predicted 1998 pe's of .15. The secrecy certainly favors us who have been willing to work hard to locate the scarce news and buy in before the news gets out. But otherwise, research is hard to come by and, in a vacuum, we can't expect investors to guess triby's value.



To: Keiko who wrote (7844)1/20/1998 9:45:00 AM
From: b muller  Read Replies (1) | Respond to of 14328
 
Keico
I hear that triby is selling urin based drugs of abuse test, whose test are they using?
B



To: Keiko who wrote (7844)1/22/1998 11:16:00 PM
From: Yo Yo  Read Replies (3) | Respond to of 14328
 
Some open questions to veteran TRIBY followers.....

I am just beginning to research TRIBY and was wondering if some
of you veterans might be able to answer a couple of questions.

1) Does the company report GAPP compliant quarterly financial
statements anywhere? The stuff on their web page is ancient 1996
data in a different format, and I did not see anything in EDGAR.

2) The cash position seems to be dwindling, is there any concern
about the need for more financing in the next quarter or two???
I.E. possible secondary offering?

3) Is the $0.06 per share 4th quarter earnings estimate on First
Call for real? Where is it supposed to come from, increased sales
or increased margins?

I see why you folks are optimistic, the future looks bright. I
just need a little more info to help focus my crystal ball.

Thanks,
Yo Yo